Greenlight Capital - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 21 filers reported holding TALIS BIOMEDICAL CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Greenlight Capital ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$1,073,176
-2.0%
2,235,7830.0%0.05%
-16.7%
Q1 2023$1,095,534
+9.9%
2,235,7830.0%0.06%
-13.0%
Q4 2022$996,488
-34.6%
2,235,7830.0%0.07%
-36.1%
Q3 2022$1,524,000
-16.1%
2,235,7830.0%0.11%
-23.4%
Q2 2022$1,816,000
-42.4%
2,235,7830.0%0.14%
-29.5%
Q1 2022$3,152,000
-49.9%
2,235,783
+42.5%
0.20%
-44.4%
Q4 2021$6,293,0001,569,3000.36%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,073,1760.05%
GEODE CAPITAL MANAGEMENT, LLC 140,530$67,4540.00%
BlackRock Inc. 76,307$36,6280.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,476$5,0280.00%
UBS Group AG 26$120.00%
NORTHERN TRUST CORP 27,860$13,3730.00%
Renaissance Technologies 54,900$260.00%
MILLENNIUM MANAGEMENT LLC 91,463$43,9020.00%
TWO SIGMA SECURITIES, LLC 49,007$23,5230.00%
Citadel Advisors 27,900$13,3920.00%
View complete list of TALIS BIOMEDICAL CORP shareholders